In this study, quantitative proteomic analysis revealed upregulation of MCM3 in tamoxifen- and AI-resistant breast cancer cells and knockdown of MCM3 resensitized these cells to tamoxifen or letrozole and resulted in altered phosphorylation of cell cycle regulator proteins. This evidence concerns the gene MCM3 and breast carcinoma.